Lumira Ventures is a venture capital and private equity firm making late stage investments in biotherapeutic, medical technology, and consumer health companies that is headquartered in Toronto, Ontario and was founded in 1989 by Peter van der Velden. The firm also has offices in Montreal, Quebec; Vancouver, British Columbia; and Boston, Massachusetts.
Notable investments made by Lumira Ventures include: AmacaThera, Antios Therapeutics, Antiva Biosciences, Aurinia Pharmaceuticals, Bardy Diagnostics, BAROnova, Cardiac Dimensions, MAKO Surgical, Corus Pharmaceuticals, Morphotek, Celtaxsys, KAI Pharmaceuticals, Pharmasset, Alveolus, Ception Therapeutics, and Zymeworks.
Companies and organizations receiving philanthropy from Lumira Ventures include: BC's Children's Hospital, SickKids Foundation, Fondation de l’Hôpital Maisonneuve-Rosemont, St. Joseph’s Healthcare Foundation, Heart and Stroke Foundation of Canada, Sunnybrook Foundation, Montreal Heart Institute Foundation, Trillium Healthcare Partners Foundation, Princess Margaret Cancer Foundation, VGH & UBC Hospital Foundation, William Osler Health System Foundation, and St. Michaels Foundation. Events and foundations supported by Lumira Ventures are the Foundation Fighting Blindness, Chrons & Colitis, Cycle for Sight, and Heart and Stroke - Big Bike.